Ursprung des Netzwerks ersten Grades von Hisaharu Momoshima
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Daiwa Corporate Investment Co., Ltd.
 Daiwa Corporate Investment Co., Ltd. Investment ManagersFinance Daiwa Corporate Investment Co. Ltd. (Daiwa Corporate Investment) is a private equity arm of Daiwa Securities Group Inc. and is headquartered in Tokyo, Japan. The firm was founded in 1982.
12
| Subsidiary | Investment Managers | 12 |
DCI Partners KK
 DCI Partners KK Investment ManagersFinance DCI Partners KK (DCI Partners) is a venture arm of Daiwa Corporate Investment Co., Ltd. founded in 2014. The firm is headquartered in Tokyo, Japan.
3
| Subsidiary | Investment Managers | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Hisaharu Momoshima
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| DAIWA SECURITIES GROUP INC. | Investment Banks/Brokers | Director/Board Member Director/Board Member Chief Operating Officer Director of Finance/CFO | |
| HOGY MEDICAL CO.,LTD. | Medical Specialties | Director/Board Member | |
| HOTUNG INVESTMENT HOLDINGS LIMITED | Financial Conglomerates | Director/Board Member | |
| ADVANCE CREATE CO., LTD. | Insurance Brokers/Services | Director/Board Member | |
| ASANTE INCORPORATED | Miscellaneous Commercial Services | Director/Board Member | |
Daiwa Securities Co., Ltd.
 Daiwa Securities Co., Ltd. Investment Banks/BrokersFinance Daiwa Securities Co., Ltd. engages in the business of financial instruments trading services which includes underwriting securities and its related business. It also provides the online trading, brokerage, purchase and sale of securities and acts as an agent or perform agency functions. The company was founded in 1943 and is headquartered in Tokyo, Japan. | Investment Banks/Brokers | Director/Board Member Director/Board Member Director/Board Member Director of Finance/CFO | |
| SUZUMO MACHINERY COMPANY LIMITED | Industrial Machinery | Director/Board Member | |
| Aoyama Gakuin University | College/University | Undergraduate Degree | |
| SAMTY CO. | Real Estate Development | Director/Board Member | |
REGiMMUNE Corp.
 REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| MONEY PARTNERS GROUP CO.,LTD. | Investment Banks/Brokers | Director/Board Member | |
| University of Tsukuba | College/University | Graduate Degree | |
Hotung Venture Capital Corp.
 Hotung Venture Capital Corp. Investment ManagersFinance Hotung Venture Capital Corp invests in companies located in Greater China, primarily in Taiwan, China and the US. The fund focuses on companies operating in the fields of IC design & semiconductors, optoelectronics, electronic components, wireless communications, new materials, software, internet, IT services, retail, e-business, and biochemistry. It provides financing for early, expansion and later stage capital requirements. It invests in both public and private companies. | Investment Managers | Director/Board Member | |
TMRC Co. Ltd.
 TMRC Co. Ltd. Medical/Nursing ServicesHealth Services TMRC Co. Ltd. provides contract research and manufactures medicines. It develops anti-cancer products and those for cancer associated disorders. The company was founded by Hisao Ekimoto in January 2002 and is headquartered in Tokyo, Japan. | Medical/Nursing Services | Director/Board Member | |
| RIBOMIC INC. | Pharmaceuticals: Major | Director/Board Member | |
| Cardio, Inc. | Director/Board Member | ||
| Tokyo University of Science | College/University | Graduate Degree | |
Daiwa PI Partners Co. Ltd.
 Daiwa PI Partners Co. Ltd. Investment ManagersFinance Daiwa PI Partners Co. Ltd. is a Private Equity firm, a subsidiary of Daiwa Investment Management, itself a subsidiary of Daiwa Securities Group Inc. (TYO:8601), founded in 1998. Daiwa PI Partners Co. Ltd. is headquartered in Tokyo, Japan with additional office in Myanmar. | Investment Managers | Chairman | |
| RAQUALIA PHARMA INC. | Pharmaceuticals: Major | Director/Board Member | |
| AGP KK | Founder | ||
Daiwa Fund Consulting Co. Ltd.
 Daiwa Fund Consulting Co. Ltd. Investment ManagersFinance Part of Daiwa Securities Group, Inc., Daiwa Fund Consulting Co. Ltd. is a Japanese company that provides asset management, discretionary investment, and investment advisory services. The company is based in Chiyoda-ku, Japan. The company was founded in 2006. The CEO is Tetsuo Akuzawa. | Investment Managers | Director/Board Member | |
Daiwa Corporate Investment Asia Ltd.
 Daiwa Corporate Investment Asia Ltd. Investment Banks/BrokersFinance Part of Daiwa Securities Group, Inc., Daiwa Corporate Investment Asia Ltd. is a Chinese company that provides securities brokerage, investment banking, and asset management services. The company is based in Hong Kong, Hong Kong. | Investment Banks/Brokers | Director/Board Member | |
| MTG CO., LTD. | Household/Personal Care | Director/Board Member | |
| Biomass Fuel Co. Ltd. | Director/Board Member | ||
| NOILE-IMMUNE BIOTECH INC. | Pharmaceuticals: Major | Director/Board Member | |
Global X Japan Co., Ltd.
 Global X Japan Co., Ltd. Investment ManagersFinance Global X Japan Co., Ltd. is a joint venture between Daiwa Securities Group Inc., Daiwa Asset Management Co. Ltd., and X Management Company, Inc. The joint venture company was founded in 2019 and is based in Chiyoda-ku, Japan. Global X Japan Co. is the Japanese only ETF specialist asset management company in Japan, offering innovative ETF lineups such as growth themes, income types, and core types (ESG-related, etc .). The company provides research and reports to its clients. | Investment Managers | Comptroller/Controller/Auditor | |
Junten Bio Co. Ltd.
 Junten Bio Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Junten Bio Co. Ltd. is a Japanese company founded in 2018 that engages in research and development of cell and regenerative medicines. The company is based in Chuo-ku, Japan. | Miscellaneous Commercial Services | Director/Board Member | |
| Open Innovation Partners KK | President | ||
| Anekisapep KK | President | ||
| KIDSWELL BIO CORPORATION | Biotechnology | Director/Board Member |
Statistik
International
| Japan | 29 |
| Taiwan | 2 |
| Vereinigte Staaten | 2 |
| Hong Kong | 2 |
Sektoral
| Finance | 14 |
| Health Technology | 7 |
| Consumer Services | 4 |
| Commercial Services | 3 |
| Producer Manufacturing | 2 |
Operativ
| Director/Board Member | 42 |
| Corporate Officer/Principal | 10 |
| Private Equity Investor | 9 |
| Independent Dir/Board Member | 5 |
| President | 5 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Hisaharu Momoshima
- Unternehmensverbindungen
